An underground economy for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Experimental Drug Acquiring Popularity Online
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers promote the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.
Some experts stated the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or prison.
Service Reaction and Material Removal
Based on TikTok, the platform has removed violative material and banned associated hashtags and search suggestions. The company said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within minutes of entering one community, a seller shared contact information, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.
Product Information and Costs
Inside these groups, messages show dark colored packages with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Measures
A representative for Telegram said it regularly monitored dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.
